FDA Approves Galderma Laboratories' Epiduo® Acne Treatment

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2013年 / 12卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：494 / 495

页数：2

相关论文

共 50 条

[41] FDA APPROVES TREATMENT IND PROTOCOL FOR TRIMETREXATE
不详
CLINICAL PHARMACY, 1988, 7 (05): : 337 - 337
[42] FDA approves new breast cancer treatment
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (23) : 2406 - 2406
[43] FDA Approves New Topical Scar Treatment
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (02) : 218 - 218
[44] FDA approves dexmethylphenidate HCL XR for the treatment of AQHD
Naccari, C
CNS SPECTRUMS, 2005, 10 (07) : 526 - 526
[45] FDA approves nateglinide for treatment of type 2 diabetes
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (04) : 285 - +
[46] FDA fully approves new Alzheimer disease treatment
不详
NURSE PRACTITIONER, 2023, 48 (09): : 48 - 48
[47] FDA approves rasagiline for the treatment of Parkinson's disease
Ralat, J
CNS SPECTRUMS, 2006, 11 (06) : 424 - 424
[48] US FDA approves boceprevir for treatment of hepatitis C
不详
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (07) : 763 - 763
[49] FDA approves Candela vbeam™ and cbeam for wrinkle treatment
不详
JOURNAL OF CLINICAL LASER MEDICINE & SURGERY, 2002, 20 (06): : 345 - 345
[50] FDA approves duloxetine for the treatment of major depressive disorder
不详
CNS SPECTRUMS, 2004, 9 (09) : 633 - 633

← 1 2 3 4 5 →